Slate Medicines | $130,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Solid (AI for Data) | $20,000,000 | (Feb 24, 2026)
Certified by Founder
Lodge
DeepCure
start up
United States
- Boston, MA
- 08/11/2021
- Series A
- $40,000,000
DeepCure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists and biologists.
Our founding team includes some of the industry’s preeminent drug-discovery scientists and technologists.
Our vision is to use AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target.
- Industry Biotechnology Research
- Website https://deepcure.ai/
- LinkedIn https://www.linkedin.com/company/deepcure/about/
Maazah | $2,000,000 | (Feb 24, 2026)
Turgo.ai | $1,000,000 | (Feb 24, 2026)
Sherpas | $3,200,000 | (Feb 24, 2026)
Patientdesk.ai (YC W26) | $1,000,000 | (Feb 24, 2026)
Aalyria | $100,000,000 | (Feb 24, 2026)
Ubicquia, Inc | $106,000,000 | (Feb 24, 2026)
Freeform | $67,000,000 | (Feb 24, 2026)
Coral Care | $13,000,000 | (Feb 24, 2026)
Reload | $2,275,000 | (Feb 24, 2026)